Abiopharma

FDA Accepts for Review INOVIOs BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)

Cadrenal Is Rebuilding the Parts of Anticoagulation Everyone Else Gave Up On

Johnson & Johnson - Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies

60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State

Inspire Medical Systems, Inc. - Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

Enveric Biosciences Announces Patent Issuance

Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum

Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.

Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA

CareCloud Appoints Chief Strategy Officer to Lead Enterprise AI Platform as Company Enters 2026 as Its Defining AI Year